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EXPERIMENTAL ATHEROSCLEROSIS PRODUCED BY DRUG 
INHIBITION OF THE THYROID GLAND
K. Mircheva, Z. Kemileva, M. Shtereva
The numerous investigations on animals, carried out with the model 
of atherosclerosis as suggested by Anichkov, prove that changes in the cho­
lesterol metabolism (1, 2, 3, 4, 9, 11) are the basic cause for atherosclerotic 
processes. Some writers discard the possibility that charging of the organism 
with cholesterol might play an essential role in the etiology of this condition, 
and accept a diversity of effects presumably accounting for the alterations 
in the metabolism of endogenic cholesterol (5, 7, 8). The question concerning 
the type of experimental animals in which experimental atherosclerosis 
could be produced is likewise disputable. Some support the statement that 
certain animal species are not susceptible to atherosclerosis, as for instance 
rats (30, 11). At the same time, others present data demonstrating the de­
velopment of atherosclerosis in rats (4, 6, 9, 13, 14). The participation of 
the thyroid gland in the development of atherosclerosis is likewise a contro­
versial issue. The pertinent literature abounds in reports on accelerated 
development of experimental atherosclerosis following inhibition of the 
thyroid function (4, 5, 9, 13). On the other hand, data are presented, though 
scarce, proving that the thyroid gland inhibition exerts insignificant effect 
upon the development of experimenal atherosclerosis, even leading to atte­
nuation of the development of atherosclerosis (5, 10, 11).
Proceeding from the controversial data just listed, we performed the 
present study with the objective of determining the influence of the thyroid 
gland in experimental cholesterol atherosclerosis in rats.
Experimental material and method
The experiments were carried out on a group of 40 white albino rats in 
the first month of life; the younger age was selected by virtue of the fact 
that the model we wished to create was to be furthermore used in influences 
mainly exerted on young animals. The animals were equally distributed 
into four groups — the first group, in addition to the general diet, received 
a 5°0 cholesterol dose with the daily ration. The second group received the 
general diet plus 0.02 mg daily dose of thymidazol (l-methyl-2-mercapto- 
imidazol) per os for thyroid function inhibition. The third group, in addi­
tion to the general diet, received also 5% cholesterol with the daily ration 
and 0.02 mg thymidazol for inhibiting the thyroid gland. The fourth group 
consisted of control animals on general diet. In about 2 1 2 months since
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the beginning of the experiments, the diet of all the animals was suppt 
mented vyith 1 gr daily dose lard, with the purpose to increase the quantil 
of saturated fatty acids in the organism. The feeding and observations c 
the animals continued for 6 months and thereafter they were killed ar 
material was obtained for investigating the total cholesterol in the serun 
aorta, liver, kidneys and spleen after the slightly modified method of Blo< 
(8a). For greater convenience and with a view to reducing the expenditure i 
reagents, the investigations were carried out on tissues, obtained from tv 
animals of the same group, taking the mean value. The values received fro 
the different groups were subjected to statistical elaboration after the me 
hod of Student Fischer.
Results and Discussion
The changes in the quantity of the total cholesterol in the serum and i 
the organs investigated of the various animal groups differ in complianc 
with the experimental background.
Tabl e
Mean Values of Cholesterol Content in mg % in the Serum and Some Organs
Groups Serum Aorta Liver Spleen Kidneyi
1. Fed on cholesterol diet 105 1725 736 562 577
2. Hypothyroidism 80.6 618 347 532 521
3. Hypothyroidism 4- cholesterol 123 436 1265 597 644
4. Controls 117 841 482 510 588
The quantity of cholesterol in the serum does not exhibit great difference 
in the separate groups as compared to that of the control group (Fig. Г 
Merely in the animals of the group with cholesterol added to the diet an 
supplemented with thymidazol for inhibiting the thyroid function, aslig t 
increase was noted (Table 1, fig. 1), but with no statistical significance. I 
the remainder two animal groups, the cholesterol quantity was decreasec 
most strongly pronounced in the animals treated only with thymidazo 
It is of interest to notice, that the decrease is rather substantial as compare 
to control animals and affords reliability of results during statistical el; 
boration: (0.99< Pt<0.999). In this respect our data disagree with the thos 
reported by Boyd (1959—9), who claimed an increased cholesterol level i 
the plasma durirg drug inhibition of the thyroid function with thiouraci 
The explanation of these facts is rather difficult, but it could possibly b 
assumed that it is due to the different experimental animal species (h 
employed rabbits), or to the difference in the drugs used.
A greater than two-fold increase is observed in the cholesterol content i 
the wall of the aorta (Fig. 2) in the animals of the group fed on cholesterc 
(0.99<Pt<0.999), whereas in the remaining groups it is lowered. Thi 
reduction is quite apparent and statistically reliable in the group with thy 
midazol inhibition of the thyroid gland and cholesterol diet (0.90<pt<
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0.95). These findings are of interest firstly, because there is no conformity 
between the cholesterol content in the serum and in the wall of the aorta, 
and secondly, because even the slightest deposit of cholesterol in the wall 
of the aorta is registered in the animals with 
combined hypothyroidism and cholesterol di­
et. Up to a great extent these facts are con­
troversial to the findings reported by other 
authors. It may be, that the age of ihe ani­
mals also has some importance in this respect, 
accounting for the altered reaction insofar 
treatment is concerned. The accumulation of 
cholesterol in the liver is reverse to its depo­
sit in the aorta (Fig. 2).The highest cholesterol 
content is recorded in animals fed on choles­
terol with simultaneously produced drug hy­
pothyroidism. The cholesterol quantity is 
three times higher than in the control ani­
mals. Lesser, but statistically reliable is the 
increase of cholesterol in the liver of the ani­
mals from the group fed merely on cholesterol 
with no hypothyroidism. The animals treated 
only with thymidazol display a reduction of 
cholesterol content in the liver, which, compa­
red to the controls, gives statistical reliability 
(Pt =  0.95). The quantity of cholesterol in the 
spleen was increased in either group of ani­
mals, receiving cholesterol with the diet 
both treated and not treated with thymidazol.
The increase compared to controls, provides for statistical reliability of 
the results obtained. In the group treated merely with thymidazol w it­
hout additional ration of cholesterol in the food, the quantity of total 
cholesterol in the spleen is reduced, but the difference is not statistically 
reliable. Fluctuations in the quantity of total cholesterol in the kidneys are 
insignificant. Merely the reduction of cholesterol in the thymidazol treated 
group is statistically reliable. The slight increase in the remaining two 
groups is deprived of statistical reliability.
It is evident from our findings that pronounced hypercholesteremia was 
produced in none of the individual groups. It is worth mentioning that a 
general reduction of the cholesterol values is produced in the serum as well 
as in the other organs studied of the animals with hypothyroidism without 
additional cholesterol ration. The explanation of this fact is not easy, espe­
cially if controversial literature reports are considered. It could possibly 
be assumed that age exerts a certain influence upon the metabolic processes 
and autoregulation of the cholesterol metabolism, thus resulting in a more 
rapid elimination and dissociation of the cholesterol. The overdose of cho­
lesterol in the animals fed on strict cholesterol diet, leads to a considerable 
increase of the total cholesterol in the wall of the aorta, whereas the group 
fed on cholesterol in association with thymidazol treatment displays sub­
stantially lower values of total cholesterol in the wall of the aorta as compared 
to controls. It might be assumed that a certain interdependence exists bet-
serum
Fig. 1. Cholesterole content in 
the serum of white albino rats
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ween the accumulation of cholesterol in 
tent in the liver. In the animals, charged 
of the cholesterol in the wall of the
a o rta  l iv e r
Fig. 2. Cholesterine content in the 
of white alb
he wall of the aorta and its con 
merely with cholesterol, the leve 
is 1925 mg %, and in the liver i
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no rats
is 736 mg %. The animals which in addition to being charged with choleste­
rol, were also treated with thymidazol, the cholesterol content in the aorta 
is 436 mg % and in the liver 1265 mg %. It could be assumed that under 
the effect of hypothyroidism, the metabolic processes get attenuated, and 
thereby the cholesterol is excreted from the organism through the liver. 
The complexity of the interrelationships in the developing processes could 
not be explained merely on the basis of the investigations herein described; 
further studies are undoubtedly required.
On the basis of the data obtained, the following conclusions were reached:
1. The cholesterol charging of the organism leads to increased cholesterol 
deposit in the wall of the aorta and in the parenchymatous organs without 
pronounced hypercholesteremia.
2. Inhibition of the thyroid function with thymidazol reduces the cho­
lesterol concentration in the serum and in the parenchymatous organs stu­
died.
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3. The cholesterol charging on the basis of thymidazol induced hypo­
thyroidism results in a reduction of the cholesterol level in the wall of the 
aorta and increase in the parenchymatous organs investigated.
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ЗКСПЕРИМЕНТАЛЬНМЙ АТЕРОСКЛЕРОЗ ПРИ МЕДИКАМЕНТОЗНОM 
ПОДАВЛЕНИИ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЬ1
К. Мирчева, 3. Кемилева, М. Щерева 
Р Е З Ю М  Е
При зкспериментальном холестериновом атеросклерозе прослежено 
влияние щитовидной железн на уровень холестерол в сьшоротке крови, 
в аорте и в некоторих паренхиматозних органах. Опити били проведени 
над четиремя группами крие, в возрасте одного месяца. Первая группа 
получала по 5°0 холестерол ежедневното пищевого рациона, вторая 
группа получала к общей пище по 0,02 мг тимидазола в сутки через рот 
в целях подавления функции щитовидной железьп Третья группа полу­
чала по 5% холестерол ежедневното пищевого рациона и по 0.02 мг 
тимидазола. Четвертая группа являлась контрольной и животиие полу- 
чали общую пищу. Через 2 1 2 месяца после начала опитов, к пище било
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прибавлено по 1 r смальца в день. Животнше кормились в течение 6 ме- 
сяцев.
Установлено, что нагрузка холестеролом приводит к увеличенному 
отложению холестерола в стенку аорти и в паренхиматозние органи у 
крнс. При подавлении функции щитовидной железьг тимидазолом, со- 
держание холестерола в сьшоротке крови и исследованнььх органах 
уменьшается. Холестероловая нагрузка на основе гипотиреоидизма внз- 
ванного тимидазолом приводит к уменьшению содержания холестерола в 
стенке аортьг и к увеличению его в исследованнь!Х органах.
